Foamix Investigational Site # 228 — Knoxville, Tennessee

Foamix Investigational Site # 228 is a clinical research site located in Knoxville, Tennessee, United States 37922.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Foamix Investigational Site # 228 has participated in 2 clinical trials.

Therapeutic areas: Facial Papulopustular Rosacea, Papulopustular Rosacea.

Sponsors: Vyne Therapeutics Inc..

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Foamix Investigational Site # 228?

Foamix Investigational Site # 228 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Foamix Investigational Site # 228 conducted?

Foamix Investigational Site # 228 has 2 clinical trials on record. Their work covers Facial Papulopustular Rosacea, Papulopustular Rosacea.

Is Foamix Investigational Site # 228 accredited by Crixeo Health?

Foamix Investigational Site # 228 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Foamix Investigational Site # 228?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.